<DOC>
	<DOCNO>NCT02188381</DOCNO>
	<brief_summary>Hypertension single prevalent risk factor heart diseases , heart failure , kidney failure stroke . About 1 3 adult United States hypertension . Approximately 28-30 % hypertensive patient suffer resistant hypertension ( RH ) . Inflammation implicate pathogenesis hypertension . Additional data suggest involvement gut microbiota host normal cardiovascular function pathophysiology . Accumulating evidence demonstrate antibiotic treatment benefit patient acute coronary syndrome reduces incidence ischemic cardiovascular event . Even though study address effect antibiotic treatment gut microbiota , possible gut microbiota could affect neurologic inflammation . Finally , intestinal microbiota recently propose modulate blood pressure ( BP ) production short-chain fatty acid . In order investigate , investigator hypothesize gut microbiota involve neuroinflammation-mediated initiation establishment RH , target gut microbiota minocycline would produce beneficial outcome RH .</brief_summary>
	<brief_title>The Role Gut Microbiota Hypertension</brief_title>
	<detailed_description>This prospective cohort design . The study enroll 123 subject : 25 normal control , 25 subject control hypertension , 25 subject resistent hypertension 48 subject enrol NCT 02133872 . Subjects provide stool sample analysis . Subjects also provide blood sample inflammatory marker stem cell analysis .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>age &gt; 18 &lt; 80 competent willing provide consent Inclusion criterion subject group : Control subject systolic BP &lt; 140mmHg cardiovascular disease Patients control hypertension Resistant hypertension subject systolic blood pressure ( BP ) ≥140 mmHg despite ≥3 antihypertensive medication different class Subjects participate NCT 02133872 eligible participate currently pregnant pregnant last 6 month ; antibiotic treatment within 2 month study enrollment ; currently take medication ( e.g. , antibiotic , antiinflammatory agent , glucocorticoid immune modulate medication ) ; unwilling discontinue vitamin supplement , include probiotic , potentially affect gut microbiota ( vitamins/supplements medication possibly affect gut microbiota discontinue least 2wks prior stool collection ) ; history intestinal surgery , inflammatory bowel disease , celiac disease , lactose intolerance , chronic pancreatitis malabsorption disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Resistant Hypertension</keyword>
	<keyword>Uncontrolled Hypertension</keyword>
</DOC>